Various penA mutations together with mtrR, porB and ponA mutations in Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime or ceftriaxone.
about
Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrheaCurrent and future antimicrobial treatment of gonorrhoea - the rapidly evolving Neisseria gonorrhoeae continues to challengeAntimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and futureResistance to β-Lactams in Neisseria ssp Due to Chromosomally Encoded Penicillin-Binding ProteinsFirst antimicrobial resistance data and genetic characteristics of Neisseria gonorrhoeae isolates from Estonia, 2009-2013.Genomic epidemiology of Neisseria gonorrhoeae with reduced susceptibility to cefixime in the USA: a retrospective observational study.Molecular and structural analysis of mosaic variants of penicillin-binding protein 2 conferring decreased susceptibility to expanded-spectrum cephalosporins in Neisseria gonorrhoeae: role of epistatic mutations.Molecular analysis of antimicrobial resistance mechanisms in Neisseria gonorrhoeae isolates from Ontario, CanadaAntimicrobial susceptibility and genetic characteristics of Neisseria gonorrhoeae isolates from Vietnam, 2011.Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from symptomatic men attending the Nanjing sexually transmitted diseases clinic (2011-2012): genetic characteristics of isolates with reduced sensitivity to ceftriaxone.Whole-genome phylogenomic heterogeneity of Neisseria gonorrhoeae isolates with decreased cephalosporin susceptibility collected in Canada between 1989 and 2013.Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: detailed characterization of the first strain with high-level resistance to ceftriaxone.Antimicrobial susceptibility/resistance and genetic characteristics of Neisseria gonorrhoeae isolates from Poland, 2010-2012.Review and international recommendation of methods for typing neisseria gonorrhoeae isolates and their implications for improved knowledge of gonococcal epidemiology, treatment, and biologyExtensive genomic variation within clonal complexes of Neisseria meningitidis.Molecular Assay for Detection of Genetic Markers Associated with Decreased Susceptibility to Cephalosporins in Neisseria gonorrhoeae.High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failureClonally related Neisseria gonorrhoeae isolates with decreased susceptibility to the extended-spectrum cephalosporin cefotaxime in Amsterdam, the Netherlands.Antibiotic resistance in Neisseria gonorrhoeae: origin, evolution, and lessons learned for the future.Emergence of decreased susceptibility and resistance to extended-spectrum cephalosporins in Neisseria gonorrhoeae in Korea.Current epidemiology and growing resistance of gram-negative pathogens.In vitro activity of ertapenem versus ceftriaxone against Neisseria gonorrhoeae isolates with highly diverse ceftriaxone MIC values and effects of ceftriaxone resistance determinants: ertapenem for treatment of gonorrhea?Plasmid-mediated resistance to tetracyclines among Neisseria gonorrhoeae strains isolated in Poland between 2012 and 2013.Cephalosporin MIC creep among gonococci: time for a pharmacodynamic rethink?Is gonorrhea becoming untreatable?Gonococcal resistance: are cephalosporins next?Recent advances in the development and use of molecular tests to predict antimicrobial resistance in Neisseria gonorrhoeae.Antimicrobial resistance in Neisseria gonorrhoeae: history, molecular mechanisms and epidemiological aspects of an emerging global threat.Proteochemometric model for predicting the inhibition of penicillin-binding proteins.Epidemiological typing of Neisseria gonorrhoeae and detection of markers associated with antimicrobial resistance directly from urine samples using next generation sequencing.In Vitro selection of Neisseria gonorrhoeae mutants with elevated MIC values and increased resistance to cephalosporins.Phenotypic and molecular characterization of Neisseria gonorrhoeae isolates from Slovenia, 2006-12: rise and fall of the multidrug-resistant NG-MAST genogroup 1407 clone?Unique combined penA/mtrR/porB mutations and NG-MAST strain types associated with ceftriaxone and cefixime MIC increases in a 'susceptible' Neisseria gonorrhoeae population.Antimicrobial resistance, genetic resistance determinants for ceftriaxone and molecular epidemiology of Neisseria gonorrhoeae isolates in Nanjing, China.Comparative proteomics analysis of Neisseria gonorrhoeae strains in response to extended-spectrum cephalosporins.Alanine 501 Mutations in Penicillin-Binding Protein 2 from Neisseria gonorrhoeae: Structure, Mechanism, and Effects on Cephalosporin Resistance and Biological Fitness.
P2860
Q24633203-4A6E3631-3F82-4276-9597-23DD00C4BD24Q26796265-1619BEE5-B132-469C-9C78-4CE0181244A1Q26862597-12536CD5-431B-4644-81AF-C542FEA8AA13Q28080009-E010F134-4DC7-420C-BC5A-82511AB6A6FFQ30865577-E7BAAD61-CE3D-4086-9CDA-2E3E25C9DEECQ33646692-D6588FB3-C495-4C75-BCED-69A895B640A4Q34126619-8EBDEC6B-597A-4B23-97DB-1894379A69B8Q34529041-452E4BFA-30F1-4AF8-A800-17F4FE5E78FCQ34563908-44141CD5-6E25-44FE-9AAA-692F09FB44BAQ34677116-48DFD88E-11B8-4881-84BF-551E93D1979FQ34916494-318C93B5-72C6-4311-997D-00EA692B96F8Q35065794-843EFDE1-5100-40AB-9278-C4B26B91FF40Q35087427-FF75BCC9-9E12-4020-8334-8D706F2FDEECQ35090128-4C0DC564-67A5-4A6B-A95F-BDC9CA5F2C8EQ35623008-98519C92-A36C-4088-BA37-32A188C4CF85Q35757713-3A8C1828-E034-4870-8FC1-1F4E25958F02Q35806206-CDD7A860-5042-46D7-8943-E89E437B0838Q35806407-9A4C0C8F-DB2A-4832-AB8D-1D0ED007810DQ35878450-05087396-AC3B-4766-89FE-C2D16E76177EQ35962785-0A33BB55-F05B-4591-8A0A-D7592227144DQ36025192-2C7A892A-5EB0-407E-873E-11CDA1A89231Q36086360-2542315C-769D-4EE5-B8A3-8F12639CE4EEQ37531864-50C6FC95-5618-4C99-B3BC-7E6B9174CBAEQ37778640-4937EDD9-333E-4FBD-9996-F0F2B0B4A9F6Q37844851-13AA7303-9EE2-4842-AA19-B38449B4E7EBQ37848735-3459482F-8AFD-4382-9D19-03EFC9CC1830Q38652213-A2716CCE-5F84-47E7-BF04-F8BA8F462791Q38654663-3BF16FC4-CA68-42E7-990C-A0F0104600FDQ39108153-C8E3B96F-87BE-46BC-8E5F-893EB6CEB36DQ40758663-EA78F6D8-9601-407F-83CA-F9DFE08A813EQ41748778-37C18F49-1D56-41D6-B620-AC63B659C72CQ42228002-6B79480D-BCA0-42E0-A793-A1395FD9CADAQ42228137-A13F729E-F93D-424E-9DD2-0D274572CA27Q44024419-9BCE27F3-6B26-45CC-92EA-D89979650417Q47095557-591C2BA8-BA77-457D-8DDD-E82C9F5C8986Q48289899-46ACB09B-8E2F-4B5F-B6A8-CC9E0A330530
P2860
Various penA mutations together with mtrR, porB and ponA mutations in Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime or ceftriaxone.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Various penA mutations togethe ...... ty to cefixime or ceftriaxone.
@ast
Various penA mutations togethe ...... ty to cefixime or ceftriaxone.
@en
type
label
Various penA mutations togethe ...... ty to cefixime or ceftriaxone.
@ast
Various penA mutations togethe ...... ty to cefixime or ceftriaxone.
@en
prefLabel
Various penA mutations togethe ...... ty to cefixime or ceftriaxone.
@ast
Various penA mutations togethe ...... ty to cefixime or ceftriaxone.
@en
P2093
P2860
P356
P1476
Various penA mutations togethe ...... ty to cefixime or ceftriaxone.
@en
P2093
Dongeun Yong
Gyung Tae Chung
Hyukmin Lee
Kyungwon Lee
Sang-Guk Lee
Seok Hoon Jeong
Yeong Seon Lee
Yunsop Chong
P2860
P304
P356
10.1093/JAC/DKP505
P407
P577
2010-01-21T00:00:00Z